Compile Data Set for Download or QSAR
Report error Found 153 Enz. Inhib. hit(s) with Target = 'Hepatocyte growth factor receptor [D1228H]'
TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517014BDBM517014(US11104676, Example 84 | (R)-1- (cyclopropylmethyl...)
Affinity DataIC50: 1.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517033BDBM517033(US11104676, Example 103 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 1.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517049BDBM517049(US11104676, Example 119 | (R)-5-cyclopropyl-N-(3- ...)
Affinity DataIC50: 1.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517030BDBM517030(US11104676, Example 100 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 1.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517021BDBM517021(US11104676, Example 91 | (R)-1-cyclobutyl-N-(3- fl...)
Affinity DataIC50: 1.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517051BDBM517051(US11104676, Example 121 | (R)-5-bromo-N-(3- fluoro...)
Affinity DataIC50: 1.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517002BDBM517002(US11104676, Example 72 | (R) N-(3-fluoro-4-((3-((1...)
Affinity DataIC50: 2nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517011BDBM517011(US11104676, Example 81 | (S)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 2.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517082BDBM517082(US11104676, Example 152 | (S)-1-cyclobutyl-N-(3- f...)
Affinity DataIC50: 2.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517080BDBM517080(US11104676, Example 150 | (S)-1- (cyclopropylmethy...)
Affinity DataIC50: 3.30nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516997BDBM516997(US11104676, Example 67 | (R)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 3.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517044BDBM517044(US11104676, Example 114 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 3.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517078BDBM517078(US11104676, Example 148 | (S)-1-ethyl-N-(3-fluoro-...)
Affinity DataIC50: 3.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517038BDBM517038(US11104676, Example 108 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 3.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516981BDBM516981(US11104676, Example 51 | N-(4-((3-((4,4-difluoro-1...)
Affinity DataIC50: 3.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517009BDBM517009(US11104676, Example 79 | N-(3-fluoro-4-((3- (((2R,...)
Affinity DataIC50: 3.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517035BDBM517035(US11104676, Example 105 | (R)-6-cyclopropyl-N-(3- ...)
Affinity DataIC50: 3.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517099BDBM517099(US11104676, Example 169 | (S)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 3.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517032BDBM517032(US11104676, Example 102 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 4nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517036BDBM517036(US11104676, Example 106 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 4nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517022BDBM517022(US11104676, Example 92 | (R)-3-(3,4- difluoropheny...)
Affinity DataIC50: 4nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517091BDBM517091(US11104676, Example 161 | (R)-1-cyclobutyl-N-(3- f...)
Affinity DataIC50: 4.10nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517037BDBM517037(US11104676, Example 107 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 4.10nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517007BDBM517007(US11104676, Example 77 | N-(3-fluoro-4-((3-((2- hy...)
Affinity DataIC50: 4.10nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517084BDBM517084(US11104676, Example 154 | (S)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 4.30nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517003BDBM517003(US11104676, Example 73 | (R)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 4.30nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517109BDBM517109(US11104676, Example 179 | (R)-1-(cyclopropylmethyl...)
Affinity DataIC50: 4.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517045BDBM517045(US11104676, Example 115 | (R)-1-ethyl-N-(3-fluoro-...)
Affinity DataIC50: 4.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517006BDBM517006(US11104676, Example 76 | (S)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 4.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516979BDBM516979(US11104676, Example 49 | N-(3-fluoro-4-((3-((1- hy...)
Affinity DataIC50: 4.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516975BDBM516975(US11104676, Example 45 | N-(4-((3-((1,3- dihydroxy...)
Affinity DataIC50: 4.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517050BDBM517050(US11104676, Example 120 | (R)-1-(3,4- difluorophen...)
Affinity DataIC50: 5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516964BDBM516964(US11104676, Example 185 | N-(3-fluoro-4-((3-((3- h...)
Affinity DataIC50: 5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517034BDBM517034(US11104676, Example 104 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 6nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516967BDBM516967(US11104676, Example 37 | N-(3-fluoro-4-((3- (((1s,...)
Affinity DataIC50: 6.10nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517047BDBM517047((S)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)
Affinity DataIC50: 6.20nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517010BDBM517010(US11104676, Example 80 | (R)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 6.20nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517092BDBM517092(US11104676, Example 162 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 6.30nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517052BDBM517052(US11104676, Example 122 | (R)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 6.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517081BDBM517081(US11104676, Example 151 | (S)-N-(3-fluoro-4-((3- (...)
Affinity DataIC50: 6.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516998BDBM516998(US11104676, Example 68 | (S)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 6.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517040BDBM517040(US11104676, Example 110 | (R)-1-cyclopropyl-N-(3- ...)
Affinity DataIC50: 6.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516964BDBM516964(US11104676, Example 185 | N-(3-fluoro-4-((3-((3- h...)
Affinity DataIC50: 6.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517028BDBM517028(US11104676, Example 98 | (S)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 6.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517126BDBM517126(US11104676, Example 196 | N-(4-((3-amino-1H-pyrazo...)
Affinity DataIC50: 7nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516999BDBM516999(US11104676, Example 69 | N-(3-fluoro-4-((3-((1- (h...)
Affinity DataIC50: 7.10nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517094BDBM517094(US11104676, Example 164 | N-(4-((3-((4,4- difluoro...)
Affinity DataIC50: 7.30nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517072BDBM517072(US11104676, Example 142 | (R) N-(3-fluoro-4-((3-((...)
Affinity DataIC50: 7.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 517005BDBM517005(US11104676, Example 75 | (R)-N-(3-fluoro-4-((3- ((...)
Affinity DataIC50: 7.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetHepatocyte growth factor receptor [D1228H](Human)
Array Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 516985BDBM516985(US11104676, Example 55 | (R)-N-(3-fluoro-4-((3-((1...)
Affinity DataIC50: 7.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen Eu Kinase Binding technolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

Displayed 1 to 50 (of 153 total ) | Next | Last >>
Jump to: